Evidence map›Paper›PMID 41492658›Full record

ReviewSynthetic biology (Oxford, England)2025

Emerging trends in genome integration tools for precision engineering of diverse bacterial species.

Riesa K W Rohmat, Thea C T Irvine, Shivang Hina-Nilesh Joshi, Andrew M Bailey, Christopher Jenkins, David Ulaeto, Pierre Buscaill, Thomas E Gorochowski

Abstract readReview
In one paragraph

Review in Synthetic biology (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Riesa K W RohmatSchool of Biological Sciences, University of Bristol, Bristol BS8 1TQ, United Kingdom.
Thea C T IrvineSchool of Biological Sciences, University of Bristol, Bristol BS8 1TQ, United Kingdom.
Shivang Hina-Nilesh JoshiSchool of Biological Sciences, University of Bristol, Bristol BS8 1TQ, United Kingdom.
Andrew M BaileySchool of Biological Sciences, University of Bristol, Bristol BS8 1TQ, United Kingdom.
Christopher JenkinsDefence Science and Technology Laboratory, Porton Down, Wiltshire SP4 0JQ, United Kingdom.
David UlaetoDefence Science and Technology Laboratory, Porton Down, Wiltshire SP4 0JQ, United Kingdom.
Pierre BuscaillSchool of Biological Sciences, University of Bristol, Bristol BS8 1TQ, United Kingdom.
Thomas E GorochowskiSchool of Biological Sciences, University of Bristol, Bristol BS8 1TQ, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ability to precisely insert DNA payloads into a genome enables the comprehensive engineering of cellular phenotypes and the creation of new biotechnologies. To achieve such modifications, the most widely used techniques rely on a host cell's native DNA repair mechanisms like homologous recombination, which hampers their broader use in organisms lacking these capabilities. Here, we explore the current landscape of genome integration systems with a particular focus on those that function in bacteria and are precise, self-contained, and portable, placing minimal requirements on the host cell. Through a historical analysis, we observe long-term use of recombineering technologies, a recent rise in the use of CRISPR-guided systems that consist of associated integrase machinery, and growing efforts to modify non-model organisms. Looking forward, we highlight some of the remaining challenges and how synthetic genomics may offer a way to create bacterial strains optimized for extensive long-term modification. As the field of synthetic biology sets its sights on real-world impact, the effective engineering of genomes will be critical to shaping the robust phenotypes that applications demand.

Indexed as

bacteriagenome editinggenome integrationsynthetic biologysynthetic genomics

Identifiers

PMID41492658
PMCPMC12765450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.